the swiss times
en_GB English
en_GB English de_DE German fr_FR French es_ES Spanish ar Arabic
the swiss times

Spineart’s Milestone: CHF 20 Million in Convertible Financing

Spineart’s Milestone: CHF 20 Million in Convertible Financing

Wed, Mar 20th 2024

Spineart secures a pivotal CHF20 million in convertible financing

Keystone/GAETAN BALLY

Spineart has successfully raised over CHF20 million through convertible financing, marking the company’s innovation and success in spinal surgery. This financial infusion comes right after the successful enrolment in the BAGUERA® C IDE studies. According to their press release.

Jerome Trividic, the CEO of Spineart, expressed immense satisfaction with this financial round’s closure. He noted the exceptional support from both existing shareholders and new investors.

Offering Spineart’s promising future, especially with its BAGUERA® C cervical disc prosthesis.

The funds will fuel several initiatives, including novel technology investments, ongoing patient follow-ups in the BAGUERA® C IDE studies, and infrastructure expansion.

Notably, Spineart is on track to complete a new 43,000sqft manufacturing facility near Geneva by the end of 2024.

Additionally, a state-of-the-art R&D and Training Center in Dallas, Texas, is set to open this summer, further solidifying Spineart’s position at the forefront of spinal surgery innovation.

Related Stories

Council of States: Cutting Asylum Credits
Thumbnail

16 May 2024

Swiss Council of States committee recommends slashing the Federal Council's proposed funding for asylum centres by CHF...

Sunday News Round Up 19th Of May
Thumbnail

19 May 2024

Demands from the Gaza war, rising hospital violence, and hotel price hikes due to worker shortages are covered in...

Novartis Successfully Secures Takeover of German Biotech Firm Morphosys
Thumbnail

16 May 2024

Novartis meets key conditions in Morphosys takeover, achieving 79.6% acceptance and gearing up for final integration...

Commerzbank Quarterly Earnings Surge
Thumbnail

15 May 2024

Commerzbank announces a pre-tax profit of nearly €1.1 billion for Q1, marking its best quarterly performance in over...

Vetropack Layoffs: Employees Demand Compensation
Thumbnail

16 May 2024

Amid planned layoffs, Vetropack employees push for a social plan and the preservation of jobs at the Saint-Prex site....

Swiss People Think AI Is Dangerous: Survey Shows
Thumbnail

17 May 2024

Swiss survey reveals rising concerns about AI dangers and foreign Internet propaganda threatening democracy, calling...

Esprit Files For Insolvency In Europe
Thumbnail

16 May 2024

Esprit takes a significant step towards restructuring by entering insolvency for its parent and several subsidiaries in...

Stay in Touch

Noteworthy

China & USA Meet In Geneva: AI Risks
Noteworthy
13 May 2024

China & USA Meet In Geneva: AI Risks

Novartis Had A Strong Q1
Noteworthy
23 April 2024

Novartis Had A Strong Q1
the swiss times
A production of UltraSwiss AG, 6340 Baar, Switzerland

Quick Links

Home Privacy GTC Contact Us About Us
Copyright © 2024 UltraSwiss AG 2024 All rights reserved